[HTML][HTML] Advances in drug delivery to atherosclerosis: Investigating the efficiency of different nanomaterials employed for different type of drugs
Atherosclerosis is the build-up of fatty deposits in the arteries. Atherosclerosis is the main
underlying cause of cardiovascular diseases and the leading cause of global morbidity and …
underlying cause of cardiovascular diseases and the leading cause of global morbidity and …
Advances in HDL: much more than lipid transporters
S Ben-Aicha, L Badimon, G Vilahur - International Journal of Molecular …, 2020 - mdpi.com
High Density Lipoprotein (HDL) particles, beyond serving as lipid transporters and playing a
key role in reverse cholesterol transport, carry a highly variable number of proteins, micro …
key role in reverse cholesterol transport, carry a highly variable number of proteins, micro …
Site‐specific microRNA‐33 antagonism by pH‐responsive nanotherapies for treatment of atherosclerosis via regulating cholesterol efflux and adaptive immunity
C Li, Y Dou, Y Chen, Y Qi, L Li, S Han… - Advanced functional …, 2020 - Wiley Online Library
Atherosclerosis remains the leading cause of a broad spectrum of deadliest cardiovascular
diseases. MicroRNA‐33 is a new therapeutic target for atherosclerosis due to its diverse …
diseases. MicroRNA‐33 is a new therapeutic target for atherosclerosis due to its diverse …
Brothers in arms: ABCA1-and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment
SJCM Frambach, R de Haas, JAM Smeitink… - Pharmacological …, 2020 - ASPET
Atherosclerosis is a leading cause of cardiovascular disease worldwide, and
hypercholesterolemia is a major risk factor. Preventive treatments mainly focus on the …
hypercholesterolemia is a major risk factor. Preventive treatments mainly focus on the …
Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide and also
inflict major burdens on morbidity, quality of life, and societal costs. Considering that CVD …
inflict major burdens on morbidity, quality of life, and societal costs. Considering that CVD …
microRNAs associated with carotid plaque development and vulnerability: the clinician's perspective
R Badacz, T Przewłocki, J Legutko, K Żmudka… - International Journal of …, 2022 - mdpi.com
Ischemic stroke (IS) related to atherosclerosis of large arteries is one of the leading causes
of mortality and disability in developed countries. Atherosclerotic internal carotid artery …
of mortality and disability in developed countries. Atherosclerotic internal carotid artery …
microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application
V Desgagné, L Bouchard, R Guérin - Clinical Chemistry and …, 2017 - degruyter.com
Abstract microRNAs (miRNAs) are short (~ 22 nucleotides), non-coding, single-stranded
RNA molecules that regulate the expression of target genes by partial sequence-specific …
RNA molecules that regulate the expression of target genes by partial sequence-specific …
[HTML][HTML] miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer
OF Karatas, J Wang, L Shao, M Ozen, Y Zhang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Prostate cancer is one of the most frequently diagnosed neoplasms among men worldwide.
MicroRNAs (miRNAs) are involved in numerous important cellular processes including …
MicroRNAs (miRNAs) are involved in numerous important cellular processes including …
High-density lipoprotein metabolism and function in cardiovascular diseases: what about aging and diet effects?
M Morvaridzadeh, N Zoubdane, J Heshmati, M Alami… - Nutrients, 2024 - mdpi.com
Cardiovascular diseases (CVDs) have become the leading global cause of mortality,
prompting a heightened focus on identifying precise indicators for their assessment and …
prompting a heightened focus on identifying precise indicators for their assessment and …
Connecting epigenetics and inflammation in vascular senescence: state of the art, biomarkers and senotherapeutics
O Fraile-Martinez, D De Leon-Oliva, DL Boaru… - Frontiers in …, 2024 - frontiersin.org
Vascular diseases pose major health challenges, and understanding their underlying
molecular mechanisms is essential to advance therapeutic interventions. Cellular …
molecular mechanisms is essential to advance therapeutic interventions. Cellular …